Dr Suruchi Vishwasrao, Sr Scientist, Merck Life Sciences

hanuman

Active member
EP_FDDC_July_2024_09_Day1_Dr_Suruchi_Vishwasrao_Merck_LS_750.jpg





In this video:
Dr Suruchi Vishwasrao, Sr Scientist, Merck Life Sciences

Topic: Patient-centric dosage forms: Oro dispersible films

Key Highlights:
[1] Distinct advantage of ORO includes patient centricity due to ease of administration.

[2] Polyvinyl alcohol supports consistent final product quality and QbD, provides highly adaptable solutions and batch to batch consistency.

[3] Merck offers Parteck MXP 4-88 polymer, produced via hot melt extrusion technology that enables smooth processibility and forms homogeneous oro-dispersible films along with plasticizers.

The post appeared first on .
 
Top
AdBlock Detected

We get it, advertisements are annoying!

Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.

I've Disabled AdBlock